Integral Diagnostics Limited (ASX:IDX)

Market Cap	897.36M -18.7%
Revenue (ttm)	767.89M +56.1%
Net Income	14.03M +147.8%
EPS	0.04 +59.8%
Shares Out	372.35M
PE Ratio	64.24
Forward PE	16.96
Dividend	0.07 (2.88%)
Ex-Dividend Date	Mar 4, 2026

Volume	126,602
Average Volume	975,650
Open	2.410
Previous Close	2.410
Day's Range	2.390 - 2.425
52-Week Range	1.910 - 3.070
Beta	0.17
RSI	45.21
Earnings Date	Feb 23, 2026

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,025
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX